Evidence map›Paper›PMID 36691540›Full record

ArticleHeliyon2023

Heteroatoms (B, N, S) doped quantum dots as potential drug delivery system for isoniazid: insight from DFT, NCI, and QTAIM.

Henry O Edet, Hitler Louis, Terkumbur E Gber, Precious S Idante, ThankGod C Egemonye, Providence B Ashishie, Emmanuella E Oyo-Ita, Innocent Benjamin, Adedapo S Adeyinka

Erratum issuedAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Competitive adsorption of COScientific reports · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Henry O EdetComputational and Bio-Simulation Research Group, University of Calabar, Calabar, Nigeria.
Hitler LouisComputational and Bio-Simulation Research Group, University of Calabar, Calabar, Nigeria.
Terkumbur E GberComputational and Bio-Simulation Research Group, University of Calabar, Calabar, Nigeria.
Precious S IdanteComputational and Bio-Simulation Research Group, University of Calabar, Calabar, Nigeria.
ThankGod C EgemonyeComputational and Bio-Simulation Research Group, University of Calabar, Calabar, Nigeria.
Providence B AshishieDepartment of Pure and Applied Chemistry, Faculty of Physical Sciences, University of Calabar, Calabar, Nigeria.
Emmanuella E Oyo-ItaComputational and Bio-Simulation Research Group, University of Calabar, Calabar, Nigeria.
Innocent BenjaminComputational and Bio-Simulation Research Group, University of Calabar, Calabar, Nigeria.
Adedapo S AdeyinkaResearch Centre for Synthesis and Catalysis, Department of Chemical Sciences, University of Johannesburg, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxicity in drug includes target toxicity, immune hypersensitivity and off target toxicity. Recently, advances in nanotechnology in the areas of drug delivery have help reduce toxicity and enhance drug solubility and deliver drugs to target sites more efficiently. In this study, we present a novel heteroatom functionalized quantum dot (QD-NBC and QD-NBS) as an effective drug delivery system for isoniazid. The said QD has been computationally modeled to assess its effectiveness in delivering isoniazid to desired target. Density functional theory (DFT) calculations were performed on the QD at the B3LYP/6-311+G(d, p) level to assess its stability through the natural bond orbital (NBO) calculations, and frontier molecular orbital (FMO) before and after interaction with isoniazid drug to understand any change in molecular behavior of the surface. Appropriate intermolecular interactions between the QD and the drug were computed through the Quantum theory of atoms in molecules (QTAIM) and Non-covalent interaction to assess the various binding mechanism and possible interactions resulting to the effective delivery of the drug target. To understand and accurately appraise the binding energy of adsorption, DFT calculations were performed with different functionals (B3LYP, CAM-B3LYP, PBEPBE, GD3BJ & WB97XD/6-311+G (d, p)). The results from DFT calculations point the functionalized QDs to be stable with appreciable energy gap suitable for delivery purposes. The adsorption energy of the drug target with the QD is in the range of -24.73 to 33.75 kcal/mol which indicates substantial interaction of the drug with the QD surface. This absorption energy is comparable with several reported literature and thus prompt the suitability of the surface for isoniazid delivery.

Indexed as

DFTDrug deliveryInteractionIsoniazidQuantum dots

Identifiers

PMID36691540
PMCPMC9860413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.